U.S. Markets open in 2 hrs 4 mins

Inovio Pharmaceuticals, Inc. (INO)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
6.29+0.24 (+3.97%)
At close: 4:00PM EDT
People also watch
NVAXGALECLDXONCSSRPT
  • G
    G.
    G.
    ALERT!!!!!!! ****** Pump & Dump in progress. *******ALERT!!!!!
    Kimmie is regurgitating old mice study hype. Don't get sucked in.
    His hedgie buddies want to take a DUMP.
    Sell in the morning, beat the scammers out the door.

    PUMP and DUMP.

    ALERT!!!!! ALERT!!!!! ALERT!!!!!

    PUMP and DUMP
  • M
    Moonie
    Moonie
    Yup, PUMP and DUMP.
    From $6.60 in premarket on the PUMP
    to $6.59, $6.58, $6.57, $6.56, $6.55, $6.54, $6.53, $6.52, $6.51, $6.50, $6.49, $6.48, $6.47, $6.46, $6.45, $6.44, $6.43, $6.42, $6.41, $6.40, $6.39, $6.38, $6.37, $6.36, $6.35, $6.34, $6.33, $6.32, $6.31, $6.30, $6.29, $6.28, $6.27, $6.26, $6.25, $6.24, $6.23, $6.22, $6.21, $6.20, $6.19, $6.18, $6.17, $6.16, $6.15, $6.14, $6.13, $6.12, $6.11, $6.10, $6.09 ....... on the DUMP.
  • o
    options
    options
    Kimmie is continuing on his World Conference Tour junkets with stops in Boston and New York to find new gullible saps for his gravy train. The penthouse suites, caviar and champagne dinners are on the baggies tab. What's in your wallets, mike and adam?
  • d
    david
    david
    Will Inovio complete a P3 trial by 2055? Are we at half time now?
  • H
    Hugo
    Hugo
    Inovio hasa sordid 38 year history.
    It was known as Concord Energy when O & G stocks were hot.
    It became United Technology when tech stocks were hot.
    It morphed into Genetronics Biomedical when med stocks were hot.
    The Inovio Pharma name was adopted when biotech and pharma stocks were hot.

    Electroporation was hyped in the 1990s, then it failed in trials.
    Kimmie has since reincarnated the FAILED "technology".
    Inovio now also hypes a cure for whatever disease is in the news (ebola, zika, MERS, chimichunga.....) but develops nothing.
    They have hyped mice trials for infectious diseases, cures for cancer, DNA platforms, activators, pulsers, syncon, modulaters, percolaters, immunos ...... but have developed nothing in 38 years.

    How long can they continue to con gullible saps?
    Kimmie is like the elixir salesman.
    "Science" that produces nothing in nearly 4 decades is SCIENCE FICTION.
    Are you really so impressionable? Do you invest in fancy sounding names and hype or in accomplishment and actual results?

    This one has SCAM written all over it.
    Is it not so, mike?
  • S
    Setto
    Setto
    The DISCOUNTED DILUTIVE FINANCING was needed to raise more funds for managements' excessive compensation.
    2016 management compensation for 38 years of nothing:
    Kim ............ $2,973,605
    Bagarazzi .. $1,393,790
    Kies ........... $1,355,723
    Sardesai .... $1,392,782

    At least someone is making money here!!!
    They recently hired more pigs to feed at the trough.
    Over $7,000,000 for Kim, Bagarazzi, Kies and Sardesai in 2016 to run some mice studies?
  • B
    Bone
    Bone
    Ask Kimmie to show you P3 trial data, not a regurgitation of old mice study data.
  • G
    GEORGE
    GEORGE
    Get the best price in the morning, mike. This is your chance to get out.
    Someone wants to take a kimchi dump on you face. Don't be a sap all of your pathetic life.
  • G
    G.
    G.
    Amgen, founded AFTER Inovio has 16 approved drugs and 13 in Phase 3 Trials.
    Inovio has ZERO approved of anything and has ZERO completed Phase 3 Trials.
    The baggies are holding empty bags.
  • L
    Louis
    Louis
    Way OVERVALUED! $550,000,000 for hyped mice studies is TULIPMANIA.
  • i
    ignatius
    ignatius
    Kimmie's 2016 compensation: $2,973,605
    Kimmie pays himself $13,500 per day for playing with mice.
    No wonder they needed to raise more cash by diluting the baggies!
  • B
    Bone
    Bone
    "Science" that produces nothing in 38 years is SCIENCE FICTION.
  • N
    Nothingbut
    Nothingbut
    Gilead founded years AFTER Inovio has 24 approved drugs and 9 in Phase 3 Trials.
    Inovio has ZERO approved of anything and has ONE Phase 3 Trial which is sure to fail..
    Dead mice is all that baggies get here.
  • S
    Sam
    Sam
    After 38 years, Inovio is peddling a P1 trial in Korea for MERS. That is good news? LoLoL
    688 cases of MERS were reported in Saudi Arabia. Inovio is going after a huge market. LoLoL
    Kimmie wants to find a cure for Middle East terrorists infected with MERS?
    mike is hyping that as good news - LoLoL
  • N
    Nothingbut
    Nothingbut
    Yahoo shows EPS of -1.07. Inovio loses ($100,000,000) per year on mice studies?
  • a
    ali
    ali
    Partial list of TERMINATED deals (who is next?):
    1) Pharma Patch plc
    2) PharmaTronics LLC
    3) Abbott
    4) Ethicon
    5) Boehringer Ingelheim
    6) Johnson & Johnson Research Pty Ltd
    7) Chiron
    8) Valentis
    9) Genteric
    10) Vical
    11) Merck
    12) Tripep
    13) Wyeth
    14) IAVI
    15) ChronTech
    16) Medimmune
    17) Roche

    Why did they all TERMINATE the partnerships?
    Inovio has nothing that works?
    What other possible reason would they all have TERMINATED?
    They found Kimmie's warehouse of dead mice?
  • S
    Sayed
    Sayed
    VGX 3100? Kimmie is decades late to the party. There are already 13 approved drugs to treat HPV: Aldara, Imiquimod, Tagamet, Cimetidine, Tagamet HB, Podocom-25, Equaline, Podophyllum, Resinol, Podocon, Pododerm, R A, Resorcinol. Why waste shareholder funds on a trial that is sure to fail?
  • m
    mass
    mass
    Celgene founded AFTER Inovio has 22 approved drugs and 12 in Phase 3 Trials.
    Inovio has ZERO approved for anything and ONE drug in a Phase 3 Trial which is sure to fail.
    DILUTION, REVERSE SPLITS and HYPE is all that you get at Inovio.
  • S
    Sam
    Sam
    INO = I NO have nothing, not even one P3 Trial completed in 38 years.
  • P
    PENN
    PENN
    Protected antibiotic-resistance bacteria is Huge. Think about just 10% of $50B market is ~ $5B value, wow

    In another first, Inovio also published results showing its dMAb constructs targeting antibiotic-resistant bacteria protected mice when challenged with a lethal dose of drug-resistant pseudomonas -- a pneumonia-causing bacteria. Pseudomonas infections usually occur in people in the hospital or with weakened immune systems. The CDC reports each year that more than two million Americans acquire antibiotic-resistant infections that are becoming increasingly more difficult and costly to treat. The bacteria can cause infections of the blood, pneumonia, and infections following surgery that can lead to severe illness and death.